These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21802308)

  • 1. Synthesis and molecular modeling of 1H-pyrrolopyrimidine-2,4-dione derivatives as ligands for the α1-adrenoceptors.
    Pittalà V; Siracusa MA; Modica MN; Salerno L; Pedretti A; Vistoli G; Cagnotto A; Mennini T; Romeo G
    Bioorg Med Chem; 2011 Sep; 19(17):5260-76. PubMed ID: 21802308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 3-arylpiperazinylalkylpyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as novel, potent, and selective alpha1-adrenoceptor ligands.
    Patanè E; Pittalà V; Guerrera F; Salerno L; Romeo G; Siracusa MA; Russo F; Manetti F; Botta M; Mereghetti I; Cagnotto A; Mennini T
    J Med Chem; 2005 Apr; 48(7):2420-31. PubMed ID: 15801833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
    Franchini S; Prandi A; Baraldi A; Sorbi C; Tait A; Buccioni M; Marucci G; Cilia A; Pirona L; Fossa P; Cichero E; Brasili L
    Eur J Med Chem; 2010 Sep; 45(9):3740-51. PubMed ID: 20605276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
    Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
    J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Arylpiperazinylethyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives as novel, high-affinity and selective alpha(1)-adrenoceptor ligands.
    Pittalà V; Romeo G; Salerno L; Siracusa MA; Modica M; Materia L; Mereghetti I; Cagnotto A; Mennini T; Marucci G; Angeli P; Russo F
    Bioorg Med Chem Lett; 2006 Jan; 16(1):150-3. PubMed ID: 16216506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
    J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α₁-Adrenoceptor and serotonin 5-HT(1A) receptor affinity of homobivalent 4-aminoquinoline compounds: an investigation of the effect of linker length.
    Chen J; Murad AK; Wakelin LP; Denny WA; Griffith R; Finch AM
    Biochem Pharmacol; 2013 May; 85(10):1534-41. PubMed ID: 23524075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore models based studies on the affinity and selectivity toward 5-HT1A with reference to α1-adrenergic receptors among arylpiperazine derivatives of phenytoin.
    Handzlik J; Szymańska E; Nędza K; Kubacka M; Siwek A; Mogilski S; Handzlik J; Filipek B; Kieć-Kononowicz K
    Bioorg Med Chem; 2011 Feb; 19(3):1349-60. PubMed ID: 21232965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
    Romeo G; Materia L; Manetti F; Cagnotto A; Mennini T; Nicoletti F; Botta M; Russo F; Minneman KP
    J Med Chem; 2003 Jul; 46(14):2877-94. PubMed ID: 12825930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
    Prandi A; Franchini S; Manasieva LI; Fossa P; Cichero E; Marucci G; Buccioni M; Cilia A; Pirona L; Brasili L
    J Med Chem; 2012 Jan; 55(1):23-36. PubMed ID: 22145629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CoMFA methodology in structure-activity analysis of hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives based on affinity towards 5-HT1A, 5-HT2A and alpha1-adrenergic receptors.
    Maciejewska D; Zołek T; Herold F
    J Mol Graph Model; 2006 Nov; 25(3):353-62. PubMed ID: 16542863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Campillo M; Pardo L; Delgado M; Manzanares J; Fuentes JA
    J Med Chem; 2005 Apr; 48(7):2548-58. PubMed ID: 15801844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in-vitro pharmacological evaluation of new 5-HT1A receptor ligands containing a benzotriazinone nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Frecentese F; Massarelli P; Bruni G; Collavoli E; Santagada V; Caliendo G
    Arch Pharm (Weinheim); 2008 Jan; 341(1):20-7. PubMed ID: 18072244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human α1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.
    Chen J; Campbell AP; Urmi KF; Wakelin LP; Denny WA; Griffith R; Finch AM
    Bioorg Med Chem; 2014 Nov; 22(21):5910-6. PubMed ID: 25288493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
    Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands.
    Tait A; Luppi A; Franchini S; Preziosi E; Parenti C; Buccioni M; Marucci G; Leonardi A; Poggesi E; Brasili L
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1185-8. PubMed ID: 15686938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rationale for the activity profile of arylpiperazinylthioalkyls as 5-HT1A-serotonin and alpha1-adrenergic receptor ligands.
    Sharma BK; Sarbhai K; Singh P
    Eur J Med Chem; 2010 May; 45(5):1927-34. PubMed ID: 20129717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
    Herold F; Król M; Kleps J; Nowak G
    Eur J Med Chem; 2006 Jan; 41(1):125-34. PubMed ID: 16263195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives: analogues of HEAT as ligands for the alpha1-adrenergic receptor subtypes.
    Romeo G; Materia L; Pittalà V; Modica M; Salerno L; Siracusa M; Russo F; Minneman KP
    Bioorg Med Chem; 2006 Aug; 14(15):5211-9. PubMed ID: 16647264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.